Stock listing
Frankfurt:2X1 Abivax SA Aktie
German listing (Frankfurt) of Abivax SA · home listing Euronext:ABVX
Follow Abivax SA into a list and get an email when it puts out news.
Share price · FWB:2X1
€77.00 EUR +1.15 (+1.5%)
Close on Nov 17, 2026
- Day range
- €74.65 – €77.00 EURNov 17, 2026
- Volume
- 101 sharesNov 17, 2026
- Market cap
- €6.72B EURAt the close on Nov 17, 2026 · price × 87.27M shares outstanding
- 52-week range
- €61.29 – €132.76 EURLowest and highest trades, Nov 18, 2025 – Nov 17, 2026
- Traded on an average day
- €75,985 EURMedian day 24 shares · 28 days with no trades · last 3 months, Aug 17, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Euronext:ABVX · Home | €75.50 EUR | -1.40 (-1.8%) | 128,059 | €75.20 | €76.15 | €74.25 | €76.90 | Close on Nov 17, 2026 |
| NASDAQ:ABVX | $82.10 USD | -1.51 (-1.8%) | 1,372,710 | $82.86 | $84.31 | $81.83 | $83.61 | Close on Nov 17, 2026 |
| LSE:0RA9 | €75.15 EUR | -1.75 (-2.3%) | 2,062 | €76.00 | €76.00 | €74.60 | €76.90 | Close on Nov 17, 2026 |
| OTC:AAVXF | $84.80 USD | 0.00 (0.0%) | — | $84.80 | $84.80 | $84.80 | $84.80 | Close on Nov 6, 2026 |
| Frankfurt:2X1 | €77.00 EUR | +1.15 (+1.5%) | 101 | €74.65 | €77.00 | €74.65 | €75.85 | Close on Nov 17, 2026 |
| Frankfurt:2X10 | €74.00 EUR | -3.50 (-4.5%) | 40 | €74.00 | €74.00 | €74.00 | €77.50 | Close on Nov 17, 2026 |
Daily closes
Last 3 months, Aug 17, 2026 – Nov 6, 2026 · FWB:2X1 · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €75.50 | -0.924 | -1.2% | €75.08 | €75.57 | €74.89 | 0 | |
| €76.42 | -1.941 | -2.5% | €78.39 | €78.59 | €76.34 | 502 | |
| €78.36 | +3.568 | +4.8% | €78.65 | €78.74 | €77.93 | 2,954 | |
| €74.79 | -0.526 | -0.7% | €74.79 | €74.79 | €74.79 | 0 | |
| €75.32 | -1.263 | -1.6% | €77.09 | €77.22 | €75.18 | 370 | |
| €76.58 | -3.505 | -4.4% | €79.21 | €79.48 | €75.90 | 370 | |
| €80.09 | +0.937 | +1.2% | €80.27 | €80.28 | €80.00 | 279 | |
| €79.15 | +2.51 | +3.3% | €79.14 | €79.15 | €78.98 | 1,210 | |
| €76.64 | -0.809 | -1.0% | €76.64 | €76.64 | €76.64 | 0 | |
| €77.45 | -2.985 | -3.7% | €77.98 | €78.51 | €77.31 | 120 | |
| €80.43 | -3.964 | -4.7% | €80.43 | €80.43 | €80.43 | 3,240 | |
| €84.40 | +1.618 | +2.0% | €84.40 | €84.40 | €84.40 | 60 | |
| €82.78 | +1.659 | +2.0% | €82.78 | €82.78 | €82.78 | 0 | |
| €81.12 | +1.881 | +2.4% | €79.76 | €81.24 | €79.37 | 250 | |
| €79.24 | -2.306 | -2.8% | €78.56 | €79.25 | €74.39 | 0 | |
| €81.55 | +3.813 | +4.9% | €81.55 | €81.55 | €81.55 | 0 | |
| €77.73 | +1.435 | +1.9% | €77.73 | €77.73 | €77.73 | 0 | |
| €76.30 | -1.945 | -2.5% | €76.30 | €76.30 | €76.30 | 0 | |
| €78.24 | -0.108 | -0.1% | €78.25 | €78.77 | €78.17 | 136 | |
| €78.35 | -0.573 | -0.7% | €78.35 | €78.35 | €78.35 | 0 | |
| €78.92 | +1.349 | +1.7% | €79.03 | €79.12 | €78.88 | 1,100 | |
| €77.57 | +0.039 | +0.1% | €77.57 | €77.57 | €77.57 | 4,318 | |
| €77.54 | -2.586 | -3.2% | €78.10 | €79.04 | €77.22 | 40 | |
| €80.12 | -1.424 | -1.7% | €80.26 | €80.28 | €79.89 | 200 | |
| €81.55 | -1.91 | -2.3% | €81.55 | €81.55 | €81.55 | 0 | |
| €83.46 | -2.068 | -2.4% | €83.68 | €84.17 | €83.02 | 30 | |
| €85.52 | -0.135 | -0.2% | €87.29 | €87.70 | €85.26 | 0 | |
| €85.66 | +0.795 | +0.9% | €85.66 | €85.66 | €85.66 | 0 | |
| €84.86 | +0.177 | +0.2% | €84.86 | €84.86 | €84.86 | 0 | |
| €84.69 | +3.149 | +3.9% | €81.09 | €85.20 | €80.98 | 0 | |
| €81.54 | -0.532 | -0.6% | €81.57 | €81.57 | €81.48 | 824 | |
| €82.07 | -3.196 | -3.7% | €82.07 | €82.07 | €82.07 | 0 | |
| €85.27 | -3.499 | -3.9% | €85.39 | €85.43 | €85.14 | 0 | |
| €88.76 | -1.301 | -1.4% | €89.79 | €90.10 | €88.74 | 225 | |
| €90.07 | -4.186 | -4.4% | €93.63 | €93.68 | €89.70 | 130 | |
| €94.25 | +3.228 | +3.5% | €93.37 | €94.43 | €92.94 | 891 | |
| €91.02 | -1.709 | -1.8% | €91.02 | €91.02 | €91.02 | 0 | |
| €92.73 | -3.252 | -3.4% | €92.73 | €92.73 | €92.73 | 0 | |
| €95.98 | -3.981 | -4.0% | €97.00 | €97.65 | €94.57 | 68 | |
| €99.97 | +0.27 | +0.3% | €101.42 | €102.95 | €99.91 | 10 | |
| €99.70 | -4.475 | -4.3% | €99.51 | €99.78 | €99.46 | 1,929 | |
| €104.17 | +2.341 | +2.3% | €104.28 | €104.28 | €103.33 | 100 | |
| €101.83 | +4.449 | +4.6% | €100.79 | €102.71 | €100.21 | 0 | |
| €97.38 | -0.496 | -0.5% | €97.38 | €97.38 | €97.38 | 0 | |
| €97.88 | +0.469 | +0.5% | €97.88 | €97.88 | €97.88 | 0 | |
| €97.41 | +1.975 | +2.1% | €97.41 | €97.41 | €97.41 | 1,589 | |
| €95.43 | -1.783 | -1.8% | €95.43 | €95.43 | €95.43 | 0 | |
| €97.22 | +1.652 | +1.7% | €97.22 | €97.22 | €97.22 | 0 | |
| €95.56 | -1.413 | -1.5% | €95.56 | €95.56 | €95.56 | 0 | |
| €96.98 | -1.181 | -1.2% | €96.98 | €96.98 | €96.98 | 0 | |
| €98.16 | -3.845 | -3.8% | €98.16 | €98.16 | €98.16 | 27,240 | |
| €102.00 | +1.467 | +1.5% | €100.18 | €102.46 | €100.01 | 200 | |
| €100.54 | -1.997 | -1.9% | €100.54 | €100.54 | €100.54 | 0 | |
| €102.53 | +0.398 | +0.4% | €100.12 | €103.48 | €99.40 | 300 | |
| €102.13 | +3.043 | +3.1% | €102.13 | €102.13 | €102.13 | 18 | |
| €99.09 | -3.882 | -3.8% | €99.09 | €99.09 | €99.09 | 400 | |
| €102.97 | +0.821 | +0.8% | €102.97 | €102.97 | €102.97 | 0 | |
| €102.15 | -0.70 | -0.7% | €103.05 | €104.25 | €102.09 | 100 | |
| €102.85 | -0.092 | -0.1% | €102.60 | €103.35 | €102.32 | 400 | |
| €102.94 | -2.815 | -2.7% | €102.94 | €102.94 | €102.94 | 0 |
- Ticker
- Frankfurt:2X1
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Nov 2, 2026
Abivax to Participate in Upcoming Fall Investor Conferences
Latest deck · July 2026
Investor Presentation (July 2026)
Investor deck · 87 slides
Calls
Replays
Abivax (Euronext:ABVX) Q4 2023 Earnings Call
Mon, Apr 08, 2024 · 8:30 AM ET
Watch Transcript
Latest news
Abivax to Participate in Upcoming Fall Investor Conferences
Nov 2, 2026
Closed €74.79 (-0.7%) on Nov 3, 2026
Abivax participera à plusieurs conférences investisseurs cet automne
Nov 2, 2026
Closed €75.32 (-1.6%) on Nov 2, 2026
ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 30.09.26
Oct 23, 2026
Closed €80.43 (-4.7%) on Oct 23, 2026
Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026
Sep 30, 2026
Closed €85.52 (-0.2%) on Oct 1, 2026
Abivax présentera des données sur l’obéfazimod lors de l’United European Gastroenterology (UEG) Week 2026
Sep 30, 2026
Closed €85.66 (+0.9%) on Sep 30, 2026
ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.08.26
Sep 25, 2026
Closed €81.54 (-0.6%) on Sep 25, 2026
Abivax Presents Business Updates and First Half 2026 Financial Results
Sep 21, 2026
Closed €88.76 (-1.4%) on Sep 22, 2026
Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod
Jul 30, 2026
Closed €110.81 (+4.6%) on Jul 31, 2026
Abivax Strengthens Commercial Capabilities With Strategic Leadership Appointments
Jul 23, 2026
Closed €112.93 (+0.2%) on Jul 24, 2026
Abivax Announces Closing of $920 Million Public Offering
Jul 6, 2026
Closed €124.91 (-3.0%) on Jul 7, 2026
Financings
Public offering of american Depositary Shares
Jul 6, 2026
Closed: US$920M raised · Leerink Partners +5
Dealers: Leerink Partners (co-lead), Morgan Stanley (co-lead), Piper Sandler (co-lead), Guggenheim Securities (co-lead), LifeSci Capital, Van Lanschot Kempen
Use of proceeds: Together with existing cash, to finance operations into the fourth quarter of 2029
Public offering of american Depositary Shares
Jul 2, 2026
Made bigger: about US$920M · US$125 a share · Leerink Partners +5
Dealers: Leerink Partners (co-lead), Morgan Stanley & Co. LLC (co-lead), Piper Sandler & Co. (co-lead), Guggenheim Securities, LLC (co-lead), LifeSci Capital, Van Lanschot Kempen
Use of proceeds: Potential US commercialization of obefazimod, clinical R&D mainly in ulcerative colitis and Crohn's disease, and general corporate purposes
Announced Jun 30, 2026 · Made bigger Jul 1, 2026 · Made bigger Jul 2, 2026
Public offering of american Depositary Shares
Jul 28, 2025
Closed: US$747.5M raised · US$64 a share · Leerink Partners +5
Dealers: Leerink Partners (co-lead), Piper Sandler & Co. (co-lead), Guggenheim Securities, LLC (co-lead), LifeSci Capital, BTIG, Van Lanschot Kempen
Use of proceeds: Finance operations into the fourth quarter of 2027, giving 12 months of cash runway after the planned NDA submission for Ulcerative Colitis
Announced Jul 23, 2025 · Update Jul 24, 2025 · Made bigger Jul 25, 2025 · Closed Jul 28, 2025
Decks
Investor Presentation (July 2026)
Investor deck · 87 slides · July 2026
Corporate Update (June 2026)
Corporate update · 56 slides · Jun 29, 2026
Investor Presentation (June 2023)
Investor deck · 35 slides · June 2023
Investor Presentation (May 2023)
Investor deck · 35 slides · May 2023
Abivax SA on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 30 in the last 12 months · 49 in all · newest Nov 2, 2026 · oldest 2025
- Calls
- 1 call with a replay · 1 with a transcript · latest Apr 8, 2024
- Decks
- 39 decks · latest July 2026
Where Abivax SA is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Euronext:ABVX · Home listing | Euronext | France | EUR |
| NASDAQ:ABVX | NASDAQ | United States | USD |
| LS Exchange:A14UQC | LS Exchange | Germany | EUR |
| gettex:2X1 | gettex | Germany | EUR |
| LSE:0RA9 | LSE | United Kingdom | EUR |
| Xetra:2X1 | Xetra | Germany | EUR |
| Tradegate:2X1 | Tradegate | Germany | EUR |
| OTC:AAVXF | OTC | United States | USD |
| Lang & Schwarz:A14UQC | Lang & Schwarz | Germany | EUR |
| Aquis:ABVXP | Aquis | United Kingdom | EUR |
| Frankfurt:2X1 · This page | Frankfurt | Germany | EUR |
| gettex:2X10 | gettex | Germany | EUR |
| BX Swiss:ABVX | BX Swiss | Switzerland | CHF |
| Dusseldorf:2X1 | Dusseldorf | Germany | EUR |
| Lang & Schwarz:A3EWCP | Lang & Schwarz | Germany | EUR |
| Munich:2X1 | Munich | Germany | EUR |
| Hamburg:2X1 | Hamburg | Germany | EUR |
| Aquis:ABVXP | Aquis | United Kingdom | EUR |
| BOATS:ABVX | BOATS | United States | USD |
| Frankfurt:2X10 | Frankfurt | Germany | EUR |
| LS Exchange:A3EWCP | LS Exchange | Germany | EUR |
| Stuttgart:2X1 | Stuttgart | Germany | EUR |
| Turquoise:ABVXP | Turquoise | United Kingdom | EUR |
| VIE:ABVX | Vienna | Austria | EUR |
| Dusseldorf:2X10 | Dusseldorf | Germany | EUR |
| Hamburg:2X10 | Hamburg | Germany | EUR |
| Munich:2X10 | Munich | Germany | EUR |
| Stuttgart:2X10 | Stuttgart | Germany | EUR |
| Tradegate:2X10 | Tradegate | Germany | EUR |
| Hanover:2X1 | Hanover | Germany | EUR |
Log in to ask 6ix AI your own questions about Abivax SA.